Get started
Award

209057

Funded outputs count: 140
Funder award ID: 209057
OpenAlex ID: G4915529853
Circulating Inflammatory Markers and Mammographic Density Phenotypes: a Mendelian Randomization Analysis
2026 · Austin Hammermeister Suger, Tabitha A. Harrison, et al. · medRxiv
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
2026 · Billaud, Amandine, Figlioli, Gisella, et al. · Apollo (University of Cambridge)
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study
2026 · Jason L. Vassy, Anna M. Dornisch, et al. · Nature Cancer · 8
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
2025 · Daniel R. Barnes, Jonathan P. Tyrer, et al. · npj Genomic Medicine · 1
PDF
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
2025 · Barnes, Daniel R, Tyrer, Jonathan P, et al. · eScholarship (California Digital Library)
PDF
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
2025 · Amandine Billaud, Gisella Figlioli, et al. · The Breast · 2
PDF
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
2025 · Maria Zanti, Denise G. O’Mahony, et al. · Nature Communications · 11
PDF
Interactions between genetic and epidemiological factors influencing mammographic density
2025 · Austin Hammermeister Suger, Hongjie Chen, et al. · American Journal of Epidemiology
PDF
Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial risk
2024 · Robert J MacInnis, Mark A Jenkins, et al. · JNCI Cancer Spectrum · 1
Plasma prolactin and postmenopausal breast cancer risk: a pooled analysis of four prospective cohort studies
2024 · Jacob K. Kresovich, Catherine Guranich, et al. · Breast Cancer Research · 5
PDF
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics
2024 · Trishna A. Desai, Åsa K. Hedman, et al. · EBioMedicine · 27
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies
2024 · Olshan, A.F., Jung, A.Y, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers
2024 · Molly Went, Amit Sud, et al. · Nature Communications · 28
PDF
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
2024 · Figueroa, J., Lee, D.G., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2024 · Clarke, C.L., Anton-Culver, H., et al. · Kölner Universitäts PublikationsServer (Universität zu Köln)
PDF
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
2024 · Castelao, J.E., Geisler, J., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium
2024 · Ito, H., Wu, A.H., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk
2024 · Mavaddat, N., Schoemaker, M.J., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2024 · Koutros, S., Janni, W., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
2024 · Manoukian, S., Ramachandran, D., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk
2024 · Daniel R. Barnes, Jonathan P. Tyrer, et al. · medRxiv · 3
PDF
Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysis
2023 · Nikos Papadimitriou, Nabila Kazmi, et al. · Cancer Medicine · 3
PDF
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
2023 · Anqi Wang, Jiayi Shen, et al. · Nature Genetics · 146
Unravelling the Role of Iroquois Homeobox 4 and its Interplay with Androgen Receptor in Prostate Cancer
2023 · Jyotsna Batra, Janaththani Panchadsaram, et al. · Research Square · 1
PDF
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
2023 · Maria Zanti, Denise G. O'Mahony, et al. · Human Mutation · 6
Year
Topic